Shanghai Sanyou Medical Co Ltd
SSE:688085
Shanghai Sanyou Medical Co Ltd
SSE:688085
Price:
17.81
CNY
-1.6%
Market Closed
Market Cap:
¥5.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Shanghai Sanyou Medical Co Ltd
SSE:688085
|
CN |
|
P
|
Pansar Bhd
KLSE:PANSAR
|
MY |
|
Top Education Group Ltd
HKEX:1752
|
AU |
|
M
|
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
|
SA |
|
Interspace Co Ltd
TSE:2122
|
JP |
|
S
|
State Bank of India
LSE:SBID
|
IN |
|
Okapi Resources Ltd
ASX:OKR
|
AU |
|
National Company for Learning and Education SJSC
SAU:4291
|
SA |
|
Canature Health Technology Group Co Ltd
SZSE:300272
|
CN |
|
Berentzen Gruppe AG
XETRA:BEZ
|
DE |
|
T
|
Tanco Holdings Bhd
KLSE:TANCO
|
MY |
|
Dafeng TV Ltd
TWSE:6184
|
TW |
|
Grupo Financiero Banorte SAB de CV
BMV:GFNORTEO
|
MX |
Income Statement
Earnings Waterfall
Shanghai Sanyou Medical Co Ltd
Shanghai Sanyou Medical Co Ltd
Income Statement
Shanghai Sanyou Medical Co Ltd
Shanghai Sanyou Medical Co Ltd
Currency: CNY
| Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Revenue |
354
N/A
|
333
-6%
|
344
+3%
|
368
+7%
|
390
+6%
|
459
+18%
|
501
+9%
|
540
+8%
|
593
+10%
|
605
+2%
|
629
+4%
|
656
+4%
|
649
-1%
|
680
+5%
|
635
-7%
|
527
-17%
|
285
-46%
|
289
+1%
|
333
+15%
|
454
+36%
|
484
+7%
|
|
| Gross Profit | ||||||||||||||||||||||
| Cost of Revenue |
(36)
|
(32)
|
(34)
|
(39)
|
(40)
|
(47)
|
(53)
|
(57)
|
(64)
|
(63)
|
(68)
|
(71)
|
(71)
|
(83)
|
(89)
|
(95)
|
(88)
|
(97)
|
(105)
|
(146)
|
(130)
|
|
| Gross Profit |
319
N/A
|
300
-6%
|
310
+3%
|
329
+6%
|
350
+7%
|
412
+18%
|
448
+9%
|
483
+8%
|
530
+10%
|
542
+2%
|
561
+4%
|
585
+4%
|
578
-1%
|
597
+3%
|
546
-9%
|
432
-21%
|
197
-54%
|
192
-2%
|
228
+18%
|
308
+35%
|
353
+15%
|
|
| Operating Income | ||||||||||||||||||||||
| Operating Expenses |
(213)
|
(203)
|
(214)
|
(219)
|
(243)
|
(292)
|
(322)
|
(360)
|
(387)
|
(392)
|
(398)
|
(411)
|
(399)
|
(418)
|
(381)
|
(312)
|
(164)
|
(189)
|
(219)
|
(299)
|
(333)
|
|
| Selling, General & Administrative |
(197)
|
(183)
|
(189)
|
(193)
|
(207)
|
(249)
|
(278)
|
(307)
|
(326)
|
(327)
|
(332)
|
(343)
|
(337)
|
(351)
|
(310)
|
(239)
|
(110)
|
(120)
|
(145)
|
(201)
|
(226)
|
|
| Research & Development |
(16)
|
(19)
|
(22)
|
(25)
|
(31)
|
(39)
|
(42)
|
(51)
|
(52)
|
(60)
|
(61)
|
(63)
|
(54)
|
(62)
|
(65)
|
(64)
|
(50)
|
(61)
|
(64)
|
(74)
|
(85)
|
|
| Depreciation & Amortization |
(4)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
0
|
0
|
0
|
(29)
|
0
|
|
| Other Operating Expenses |
4
|
(1)
|
(2)
|
(1)
|
1
|
(4)
|
(2)
|
(1)
|
2
|
(5)
|
(5)
|
(5)
|
5
|
(5)
|
(6)
|
(9)
|
(4)
|
(8)
|
(10)
|
4
|
(22)
|
|
| Operating Income |
106
N/A
|
97
-8%
|
96
-1%
|
110
+14%
|
107
-2%
|
120
+12%
|
127
+6%
|
123
-3%
|
143
+16%
|
150
+5%
|
163
+9%
|
174
+7%
|
178
+2%
|
179
+0%
|
165
-8%
|
120
-27%
|
32
-73%
|
3
-90%
|
9
+175%
|
9
+2%
|
20
+127%
|
|
| Pre-Tax Income | ||||||||||||||||||||||
| Interest Income Expense |
3
|
3
|
4
|
8
|
23
|
29
|
33
|
35
|
61
|
60
|
58
|
57
|
56
|
55
|
46
|
40
|
(1)
|
5
|
6
|
12
|
10
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
6
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
|
| Total Other Income |
5
|
5
|
0
|
5
|
7
|
9
|
16
|
15
|
14
|
11
|
4
|
9
|
11
|
10
|
20
|
14
|
13
|
3
|
1
|
1
|
1
|
|
| Pre-Tax Income |
114
N/A
|
105
-8%
|
101
-4%
|
122
+21%
|
137
+12%
|
158
+16%
|
175
+11%
|
173
-1%
|
217
+25%
|
220
+1%
|
225
+2%
|
240
+7%
|
240
0%
|
244
+2%
|
231
-5%
|
175
-24%
|
44
-75%
|
11
-75%
|
16
+47%
|
22
+33%
|
38
+72%
|
|
| Net Income | ||||||||||||||||||||||
| Tax Provision |
(16)
|
(15)
|
(14)
|
(17)
|
(18)
|
(22)
|
(24)
|
(21)
|
(22)
|
(22)
|
(23)
|
(30)
|
(36)
|
(38)
|
(35)
|
(24)
|
(8)
|
(5)
|
(8)
|
(10)
|
(11)
|
|
| Income from Continuing Operations |
98
|
90
|
86
|
105
|
119
|
137
|
151
|
152
|
195
|
198
|
202
|
210
|
204
|
206
|
196
|
150
|
36
|
6
|
8
|
12
|
27
|
|
| Income to Minority Interest |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(9)
|
(8)
|
(10)
|
(13)
|
(13)
|
(14)
|
(19)
|
(18)
|
(7)
|
(1)
|
0
|
(1)
|
(0)
|
|
| Net Income (Common) |
98
N/A
|
90
-8%
|
86
-4%
|
105
+21%
|
119
+13%
|
137
+15%
|
151
+11%
|
152
+1%
|
186
+22%
|
190
+2%
|
193
+2%
|
198
+3%
|
191
-3%
|
192
+1%
|
177
-8%
|
132
-25%
|
30
-78%
|
5
-83%
|
9
+70%
|
11
+34%
|
26
+130%
|
|
| EPS (Diluted) |
0.32
N/A
|
0.4
+25%
|
0.28
-30%
|
0.35
+25%
|
0.39
+11%
|
0.45
+15%
|
0.5
+11%
|
0.51
+2%
|
0.62
+22%
|
0.63
+2%
|
0.64
+2%
|
0.66
+3%
|
0.64
-3%
|
0.64
N/A
|
0.59
-8%
|
0.46
-22%
|
0.09
-80%
|
0.02
-78%
|
0.03
+50%
|
0.05
+67%
|
0.07
+40%
|
|
Switch to:
Switch to:
See Also
Discover More
